Utilize este identificador para referenciar este registo: https://hdl.handle.net/10216/141473
Registo completo
Campo DCValorIdioma
dc.creatorPádua, D
dc.creatorBarros, R
dc.creatorAmaral, AL
dc.creatorMesquita, P
dc.creatorFreire, AF
dc.creatorSousa, M
dc.creatorMaia, AF
dc.creatorCaiado, I
dc.creatorFernandes, H
dc.creatorPombinho, AR
dc.creatorPereira, CF
dc.creatorAlmeida, R
dc.date.accessioned2022-06-27T10:35:28Z-
dc.date.available2022-06-27T10:35:28Z-
dc.date.issued2020
dc.identifier.issn2072-6694
dc.identifier.urihttps://hdl.handle.net/10216/141473-
dc.description.abstractGastric cancer remains a serious health burden with few therapeutic options. Therefore, the recognition of cancer stem cells (CSCs) as seeds of the tumorigenic process makes them a prime therapeutic target. Knowing that the transcription factors SOX2 and OCT4 promote stemness, our approach was to isolate stem-like cells in human gastric cancer cell lines using a traceable reporter system based on SOX2/OCT4 activity (SORE6-GFP). Cells transduced with the SORE6-GFP reporter system were sorted into SORE6+ and SORE6– cell populations, and their biological behavior characterized. SORE6+ cells were enriched for SOX2 and exhibited CSC features, including a greater ability to proliferate and form gastrospheres in non-adherent conditions, a larger in vivo tumor initiating capability, and increased resistance to 5-fluorouracil (5-FU) treatment. The overexpression and knockdown of SOX2 revealed a crucial role of SOX2 in cell proliferation and drug resistance. By combining the reporter system with a high-throughput screening of pharmacologically active small molecules we identified monensin, an ionophore antibiotic, displaying selective toxicity to SORE6+ cells. The ability of SORE6-GFP reporter system to recognize cancer stem-like cells facilitates our understanding of gastric CSC biology and serves as a platform for the identification of powerful therapeutics for targeting gastric CSCs.
dc.description.sponsorshipThis research was funded by This work was supported by FEDER-Fundo Europeu de Desenvolvimento Regional funds through the COMPETE 2020–Operacional Programme for Competitiveness and Internationalisation (POCI), Portugal 2020, and by Portuguese funds through FCT–Fundação para a Ciência e a Tecnologia/Ministério da Ciência, Tecnologia e Inovação in the framework of the project “Institute for Research and Innovation in Health Sciences” (POCI-01-0145-FEDER-007274); project NORTE-07-0124-FEDER-000029 supported by Norte Portugal Regional Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (ERDF); and projects POCI-01-0145-FEDER-029017 and POCI-01-0145-FEDER-016390 funded by FCT. Diana Pádua acknowledges FCT for financial support through a PhD fellowship (SFRH/BD/146186/2019).
dc.language.isoeng
dc.publisherMDPI
dc.relation.ispartofCancers, vol.12(2):495
dc.rightsopenAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleA SOX2 reporter system identifies gastric cancer stem-like cells sensitive to monensin
dc.typeArtigo em Revista Científica Internacional
dc.contributor.uportoInstituto de Investigação e Inovação em Saúde
dc.identifier.doi10.3390/cancers12020495
dc.relation.publisherversionhttps://www.mdpi.com/2072-6694/12/2/495
Aparece nas coleções:I3S - Artigo em Revista Científica Internacional

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
10.3390-cancers12020495.pdf3.71 MBAdobe PDFThumbnail
Ver/Abrir


Este registo está protegido por Licença Creative Commons Creative Commons